Pharma


  • Image attribution tooltip
    Permission granted by Vidya Viswanathan

    Tracking trends in healthcare, from tech to patient care

    High-performing leaders honored by the Healthcare Businesswomen’s Association share their views on the future of the industry.

    By May 20, 2022
  • Image attribution tooltip
    iStock via Getty Images
    Q&A

    Ironwood Pharmaceuticals is charting a course to become a giant in GI

    Ironwood’s CEO, Tom McCourt, discusses the company’s strategy for leveling up in the GI market. 

    By May 19, 2022
  • Image attribution tooltip
    John Moore via Getty Images

    A potential COVID-19 EUA could turn this small biotech into a household name

    Veru’s CEO discusses the impact of the upcoming FDA decision on its treatment targeting severely ill COVID-19 patients.

    By May 19, 2022
  • Image attribution tooltip
    Permission granted by SpringWorks/Jim Cassidy
    Profile

    Jumping into pharma with big plans at a small company

    SpringWorks Therapeutics' chief medical officer on the ambition that drives him and his company to develop treatments for cancer patients.

    By Alexandra Pecci • May 17, 2022
  • Image attribution tooltip
    Spencer Platt via Getty Images
    Q&A

    BriOri BioTech sets the stage for the comeback of Vioxx

    With a topical pain-relieving ointment in development, the emerging biotech is aiming to give the tarnished NSAID a new life.

    By Kelly Bilodeau • May 17, 2022
  • Image attribution tooltip
    Stock via Getty Images

    Are digital DCTs the answer for rare diseases?

    How data from EHRs is helping to identify, diagnose and recruit patients to decentralized clinical trials.

    By Kim Ribbink • May 16, 2022
  • Image attribution tooltip
    iStock via Getty Images

    After 40 years, researchers discover new frontiers in the fight against HIV

    Medical advances in the last two decades may now provide scientists with the right toolbox to target the long-elusive virus.

    By May 16, 2022
  • Image attribution tooltip
    Westend61 via Getty Images
    Sponsored by GoodRx

    A better approach to boosting patient engagement

    GoodRx solutions help biopharma brands overcome common barriers & increase patient engagement.

    May 16, 2022
  • Image attribution tooltip

    Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma and one of this year's HBA Luminary honorees. 

    Opinion

    Why 'soft' skills matter in the new era of leadership

    Standout leaders honored by the Healthcare Businesswomen's Association discuss the rising value of the interpersonal approach.

    By May 12, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: AiCure's Michelle Marlborough

    As chief product officer at AiCure, Michelle Marlborough is focused on solving tough patient challenges through technology.

    By May 11, 2022
  • Image attribution tooltip
    Stock via Getty Images

    In the hot pharma talent market, execs battle these recruitment misconceptions

    One of the top recruiting firms in life sciences weighs in on how companies can attract the next wave of rising stars.

    By May 11, 2022
  • Image attribution tooltip
    iStock via Getty Images

    It's time to acknowledge access as a prescribing barrier

    A new survey reveals how red tape limits patient access to doctor-preferred specialty drugs. 

    By May 11, 2022
  • Image attribution tooltip
    Sarah Silbiger via Getty Images

    FDA draft guidance may turn diversity in clinical trials from nice-to-have into a must-have

    New guidance from the FDA will ‘up the ante’ for diversity considerations. Here’s how your company can prepare.

    By Kelly Bilodeau • May 10, 2022
  • Image attribution tooltip
    Permission granted by Replimune/Philip Astley-Sparke

    Where hope and uncertainty meet: A cutting-edge cancer developer's winding road

    Replimune is on the precipice of a new kind of cancer treatment, but its CEO knows something about ambiguity.

    By Alexandra Pecci • May 9, 2022
  • Image attribution tooltip
    Monty Rakusen via Getty Images
    Sponsored by CorEvitas

    Understanding real-world data in the real world

    Real-world data (RWD) and real-world evidence (RWE) are valuable across the entire pharmaceutical product lifecycle, from examining patient outcomes to supporting disease education and awareness and beyond. 

    By Molly Namiotka • May 9, 2022
  • Image attribution tooltip
    iStock via Getty Images

    Pharma's solution to the digital advertising dilemma? Storytelling

    Peter Shin, vice president of Client Services at Sonic Health, says quality storytelling, rather than trendy content, is central to a digital advertising strategy.

    By May 5, 2022
  • Image attribution tooltip
    National Institute on Aging. (2017). "Beta-Amyloid Plaques and Tau in the Brain" [Image]. Retrieved from Flickr.

    Ultra-sensitive tests bring biomarkers into the drug development forefront

    An agreement between the biomarker assay maker Quanterix and pharma giant Eli Lilly could help discover new ways to treat Alzheimer's.

    By May 5, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Amgen's Dr. Jane Parnes

    As executive medical director, early development at Amgen, Dr. Jane Parnes has helped guide clinical research for upwards of 30 of the company’s investigational molecules, including the newly approved Tezspire for severe asthma — one of her career highlights.

    By May 4, 2022
  • Image attribution tooltip
    iStock via Getty Images
    Profile

    Breaking new ground: Longhorn's trailblazing effort to develop a universal flu vaccine

    After years of success with their diagnostic platform for COVID-19, tuberculosis and the flu, the family funded company is shifting priorities back to the vaccine market.

    By , May 4, 2022
  • Image attribution tooltip

    Permission granted by Nelson Ambrogio.

    Profile

    Bayer executive makes strides toward a finish line for rare cancers

    Bayer's SVP and general manager of U.S. oncology completed the Boston Marathon to honor his brother and bring attention to rare cancers.

    By Alexandra Pecci • May 3, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Profile

    From cancer survivor to clinical trial innovator

    How Alicia Staley is using her insights as a three-time cancer survivor to drive clinical trial improvements at Medidata.

    By Kelly Bilodeau • May 3, 2022
  • Image attribution tooltip
    Stock via Getty Images

    A nuclear threat spurs France's Medesis to advance radiation therapy

    In the event of a nuclear event — intentional or accidental — rapid and widespread deployment of effective treatments is paramount.

    By Kelly Bilodeau • May 2, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    One company's failed drug is this company's 'jewel'

    Dr. Thomas Bock, CEO of Notable, is helping the company develop a ‘new class’ of predictive precision medicines in oncology.

    By May 2, 2022
  • Image attribution tooltip
    doug4537 via Getty Images

    The 'innovation gap' haunts Big Pharma, and the race is on for the next blockbusters

    The next big innovation wave is out there, and as pharmas expect massive losses without enough internal R&D to fill those shoes, smaller biotechs beckon.

    By April 28, 2022
  • Image attribution tooltip

    Permission granted by Alan Millar. 

    Q&A

    How an open platform can shake up the drug development process

    TetraScience’s Alan Millar shares why pharma is rethinking data integration in the race to be faster, better and more effective.

    By Kim Ribbink • April 28, 2022